Founded in 1997, ERGOMED Group is dedicated to providing specialized services to the pharmaceutical and biotechnology industries, supporting the development of new drugs.
With a global footprint covering 100+ countries, we have the reach to deliver solutions for even the toughest clinical development and trial management challenges.
Ergomed has provided clinical development, pharmacovigilance, audit consulting services for 300+ clients, from top 10 pharmaceutical and generics organizations to small and mid-sized drug development companies.




Ergomed begins
First co-development deal
PrimeVigilance launches
Ergomed IPO
Aquisiton of Sound Opinion
Acquisition of Haemostatix
Acquisition of O+P, GASD
Acquisition of PharmInvent
Acquisition of PSR
Acquisition of Ashfield PV
Acquisition of MedSource
Acquisition of ADAMAS
Permira completes acquisition of Ergomed
Acquisition of Panacea